Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme

Overview of attention for article published in BMC Cancer, February 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND FOLFIRI

Application WO-2021214221-A1

World Intellectual Property Organisation (WIPO)

ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND FOLFOX

Application WO-2021214223-A1

World Intellectual Property Organisation (WIPO)

ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND CETUXIMAB

Application WO-2021214227-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.